PANG — Pangaea Oncology SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Pangaea Oncology SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2.13	-4.98	-1.91	-1.1	-2.84
Depreciation
Amortisation
Non-Cash Items	-2.31	0.162	-2.1	-1.52	-1.88
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.251	-0.655	-0.321	-0.873	-0.195
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2.17	-2.4	-1.92	-2.5	-3.68
Capital Expenditures	-0.027	-0.001	-0.071	-0.03	-0.02
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.058	-0.019	-0.119	-0.768	-0.725
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-0.086	-0.02	-0.19	-0.797	-0.746
Financing Cash Flow Items	2.49	—	—	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2.6	2.09	2.04	5.08	9.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.353	-0.328	-0.088	1.77	5.08